1Shao J, Cui YX, Cao LF. Efficacy and safety of sublingual immu- notherapy in children aged 3-13 years with allergic rhinitis[ J]. Am J Rhinol Allergy, 2013,38:843-850.
6Passalacqua G, Musarra A, Pecora S, et al. Quantitative assess- ment of the compliance with a once-daily sublingual immunotherapy regimen in real life ( EASY Project: Evaluation of A novel SLIT formulation during a Year) [ J]. J Allergy Clin Immunol, 2006, 117(4) :946-948.
7Marogna M, Spadolni I, Massolo A, et al. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more [ J ]. Allergy, 2004,59 (11 ) : 1205-1210.
8Incorvaia C, Mauro M, Ridolo E, et al. Patient's compliance with allergen immunotherapy [ J ]. Patient Prefer Adherence, 2008,2 : 247-251.
9Lombardi C, Gani F, Landi M, et al. Quantitaive assessment of the adherence to sbulingual immunotherapy[ J]. J Allergy Clin Im- munol, 2004,113 (6) : 1219-1220.
8BOUSQUET J,VAN CAUWENBERGE P,KHALTAEV N,et al.Allergic rhinitis and its impact on asthma[J].J Allergy Clin Immunol,2001,108(Suppl 5):S146-150.
9PASSALACQUA G,MUSARRA A,PECORA S,et al.Quantitative assessment of the compliance with a once-daily sublingual immunotherapy regimen in real life (EASY Project:Evaluation of a novel SLIT formulation during a year)[J].J Allergy Clin Immunol,2006,117:946-948.
10SCADDING G K,BROSTOFF J.Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite[J].Clin Allergy,1986,16:483-491.
